Qiagen NV (NYSE:QGEN)
| 52.77 Delayed Data As of Jul 30 |  +0.55 / +1.05%Today’s Change | 45.33 Today|||52-Week Range 59.00 | -0.15% Year-to-Date |
Latest QGEN News | Press Releases
| QIAGEN (QGEN) Q2 Earnings Top Estimates, Margins Decline Jul 30 / Zacks.com - Paid Partner Content | Qiagen (QGEN) Earnings Expected to Grow: What to Know Ahead of Next Week's Release Jul 22 / Zacks.com - Paid Partner Content |
| Qiagen (QGEN) Beats Q2 Earnings and Revenue Estimates Jul 29 / Zacks.com - Paid Partner Content |
Today’s Trading
| Previous close | 52.22 |
| Today’s open | 53.60 |
| Day’s range | 52.72 - 54.01 |
| Volume | 1,335,973 |
| Average volume (3 months) | 760,564 |
| Market cap | $12.0B |
Data as of 3:59pm ET, 07/30/2021
Growth & Valuation
| Earnings growth (last year) | -- |
| Earnings growth (this year) | +13.02% |
| Earnings growth (next 5 years) | +0.17% |
| Revenue growth (last year) | +22.53% |
| P/E ratio | 27.5 |
| Price/Sales | 6.62 |
| Price/Book | 4.24 |
Competitors
| Today’s change | Today’s % change | |
|---|---|---|
| BRKRBruker Corp | +0.34 | +0.42% |
| BIOBio Rad Laboratories... | +32.40 | +4.58% |
| PACBPacific Biosciences ... | +0.46 | +1.45% |
| PKIPerkinElmer Inc | +2.91 | +1.62% |
Data as of 4:28pm ET, 07/30/2021
Financials
| Last reporting date | July 30, 2021 |
| EPS forecast (this quarter) | $0.66 |
| Annual revenue (last year) | $1.9B |
| Annual profit (last year) | $359.2M |
| Net profit margin | 19.20% |
Profile
Sector Health Technology |
Industry Medical Specialties |
No executives to display |
Corporate headquarters Venlo, Limburg |
Forecasts
